检索结果 - Christine A. Pratilas

Refine Results
  1. 1
    Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response

    Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response 由 Christine A. Pratilas, David B. Solit

    出版 2010
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Targeting Oncogenic BRAF in Human Cancer

    Targeting Oncogenic BRAF in Human Cancer 由 Christine A. Pratilas, Feng Xing, David B. Solit

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor

    From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor 由 Kathryn M. Lemberg, Jiawan Wang, Christine A. Pratilas

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors

    BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors 由 Karisa C. Schreck, Stuart A. Grossman, Christine A. Pratilas

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    <sup>V600E</sup> BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway

    <sup>V600E</sup> BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway 由 Christine A. Pratilas, Barry S. Taylor, Qing Ye, Agnès Viale, Chris Sander, David B. Solit, Neal Rosen

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance

    Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance 由 Grazia Ambrosini, Christine A. Pratilas, Li-Xuan Qin, Madhavi Tadi, Oliver Surriga, Richard D. Carvajal, Gary K. Schwartz

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Models from experiments: combinatorial drug perturbations of cancer cells

    Models from experiments: combinatorial drug perturbations of cancer cells 由 Sven Nelander, Weiqing Wang, Bengt‐Olof Nilsson, Qing‐Bai She, Christine A. Pratilas, Neal Rosen, Peter Gennemark, Chris Sander

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors

    Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors 由 Jiawan Wang, Kai Pollard, Amy N. Allen, Tushar Tomar, Dirk Pijnenburg, Zhan Yao, Fausto J. Rodríguez, Christine A. Pratilas

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Integrated molecular and clinical analysis of BRAF-mutant glioma in adults

    Integrated molecular and clinical analysis of BRAF-mutant glioma in adults 由 Karisa C. Schreck, Pinky Langat, Varun Bhave, Taibo Li, E. L. Woodward, Christine A. Pratilas, Charles G. Eberhart, Wenya Linda Bi

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat

    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat 由 Erin E. Resch, Stavriani C. Makri, Paola Ghanem, Ezra Baraban, Kenneth J. Cohen, Alan R. Cohen, Evan J. Lipson, Christine A. Pratilas

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    BRAFV600E Mutation Is Associated with Preferential Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibition in Thyroid Cancer Cell Lines

    BRAFV600E Mutation Is Associated with Preferential Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibition in Thyroid Cancer Cell Lines 由 Rébecca Leboeuf, Jacqueline E. Baumgartner, Miriam Benezra, Roberta Malaguarnera, David B. Solit, Christine A. Pratilas, Neal Rosen, Jeffrey A. Knauf, James A. Fagin

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition

    3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition 由 David B. Solit, Elmer Santos, Christine A. Pratilas, Jose Lobo, Maxim A. Moroz, Shangde Cai, Ronald Blasberg, Judith S. Sebolt‐Leopold, Steven M. Larson, Neal Rosen

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer

    Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer 由 Erin M. Tricker, Chunxiao Xu, Sharmeen Uddin, Marzia Capelletti, Dalia Ercan, Atsuko Ogino, Christine A. Pratilas, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase–Driven Leukemias and Other Malignancies

    Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase–Driven Leukemias and Other Malignancies 由 J. Kyle Bruner, S. Hayley, Li Li, Alice Can Ran Qin, Michelle A. Rudek, Richard J. Jones, Mark J. Levis, Keith W. Pratz, Christine A. Pratilas, Donald Small

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Novel PAX3::MAML3 fusion identified in alveolar rhabdomyosarcoma, using DNA methylation profiling to expand the genetic spectrum of “fusion-positive” cases

    Novel PAX3::MAML3 fusion identified in alveolar rhabdomyosarcoma, using DNA methylation profiling to expand the genetic spectrum of “fusion-positive” cases 由 Josephine K. Dermawan, Faizan Malik, John Gross, Ezra Baraban, Christine A. Pratilas, Wadad Mneimneh, Matteo Trucco, Wenyue Sun, Frederic G. Barr, Felipe D’Almeida Costa, Karen Fritchie

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells

    Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells 由 Anil Korkut, Weiqing Wang, Emek Demir, Bülent Arman Aksoy, Xiaohong Jing, Evan Molinelli, Özgün Babur, Debra L. Bemis, S. Onur Sumer, David B. Solit, Christine A. Pratilas, Chris Sander

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Size-based detection of sarcoma circulating tumor cells and cell clusters

    Size-based detection of sarcoma circulating tumor cells and cell clusters 由 Masanori Hayashi, Peixuan Zhu, Gregory McCarty, Christian F. Meyer, Christine A. Pratilas, Adam S. Levin, Carol D. Morris, Catherine M. Albert, Kyle W. Jackson, Cha-Mei Tang, David M. Loeb

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations

    Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations 由 Doreen N. Palsgrove, Yunjie Li, Christine A. Pratilas, Ming‐Tseh Lin, Aparna Pallavajjalla, Christopher D. Gocke, Angelo M. De Marzo, Andrés Matoso, George J. Netto, Jonathan I. Epstein, Pedram Argani

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    BRAF mutation predicts sensitivity to MEK inhibition

    BRAF mutation predicts sensitivity to MEK inhibition 由 David B. Solit, Levi A. Garraway, Christine A. Pratilas, Ayana Sawai, Gad Getz, Andrea Basso, Qing Ye, Jose Lobo, Yuhong She, Iman Osman, Todd R. Golub, Judith S. Sebolt‐Leopold, William R. Sellers, Neal Rosen

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

    The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner 由 Eric W. Joseph, Christine A. Pratilas, Poulikos I. Poulikakos, Madhavi Tadi, Weiqing Wang, Barry S. Taylor, Ensar Halilovic, Yogindra Persaud, Feng Xing, Agnès Viale, James Tsai, Paul B. Chapman, Gideon Bollag, David B. Solit, Neal Rosen

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: